Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops
- PMID: 22451932
- PMCID: PMC3326499
- DOI: 10.1073/pnas.1112391109
Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops
Abstract
The HIV-1 envelope (Env) spike (gp120(3)/gp41(3)) undergoes considerable structural rearrangements to mediate virus entry into cells and to evade the host immune response. Engagement of CD4, the primary human receptor, fixes a particular conformation and primes Env for entry. The CD4-bound state, however, is prone to spontaneous inactivation and susceptible to antibody neutralization. How does unliganded HIV-1 maintain CD4-binding capacity and regulate transitions to the CD4-bound state? To define this mechanistically, we determined crystal structures of unliganded core gp120 from HIV-1 clades B, C, and E. Notably, all of these unliganded HIV-1 structures resembled the CD4-bound state. Conformational fixation with ligand selection and thermodynamic analysis of full-length and core gp120 interactions revealed that the tendency of HIV-1 gp120 to adopt the CD4-bound conformation was restrained by the V1/V2- and V3-variable loops. In parallel, we determined the structure of core gp120 in complex with the small molecule, NBD-556, which specifically recognizes the CD4-bound conformation of gp120. Neutralization by NBD-556 indicated that Env spikes on primary isolates rarely assume the CD4-bound conformation spontaneously, although they could do so when quaternary restraints were loosened. Together, the results suggest that the CD4-bound conformation represents a "ground state" for the gp120 core, with variable loop and quaternary interactions restraining unliganded gp120 from "snapping" into this conformation. A mechanism of control involving deformations in unliganded structure from a functionally critical state (e.g., the CD4-bound state) provides advantages in terms of HIV-1 Env structural diversity and resistance to antibodies and inhibitors, while maintaining elements essential for entry.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3326499/bin/pnas.1112391109fig01.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3326499/bin/pnas.1112391109fig02.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3326499/bin/pnas.1112391109fig03.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3326499/bin/pnas.1112391109fig04.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3326499/bin/pnas.1112391109fig05.gif)
Similar articles
-
Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.J Virol. 2017 Feb 14;91(5):e02219-16. doi: 10.1128/JVI.02219-16. Print 2017 Mar 1. J Virol. 2017. PMID: 28003492 Free PMC article.
-
Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.J Virol. 2016 Apr 14;90(9):4481-4493. doi: 10.1128/JVI.03206-15. Print 2016 May. J Virol. 2016. PMID: 26889042 Free PMC article.
-
Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop.Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7151-E7158. doi: 10.1073/pnas.1615939113. Epub 2016 Oct 31. Proc Natl Acad Sci U S A. 2016. PMID: 27799557 Free PMC article.
-
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.Acc Chem Res. 2014 Apr 15;47(4):1228-37. doi: 10.1021/ar4002735. Epub 2014 Feb 6. Acc Chem Res. 2014. PMID: 24502450 Free PMC article. Review.
-
Quaternary Interaction of the HIV-1 Envelope Trimer with CD4 and Neutralizing Antibodies.Viruses. 2021 Jul 20;13(7):1405. doi: 10.3390/v13071405. Viruses. 2021. PMID: 34372611 Free PMC article. Review.
Cited by
-
Antiviral Protein-Protein Interaction Inhibitors.J Med Chem. 2024 Mar 14;67(5):3205-3231. doi: 10.1021/acs.jmedchem.3c01543. Epub 2024 Feb 23. J Med Chem. 2024. PMID: 38394369 Free PMC article. Review.
-
Engaging an HIV vaccine target through the acquisition of low B cell affinity.Nat Commun. 2023 Aug 28;14(1):5249. doi: 10.1038/s41467-023-40918-2. Nat Commun. 2023. PMID: 37640732 Free PMC article.
-
Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralization.Nat Struct Mol Biol. 2023 Sep;30(9):1323-1336. doi: 10.1038/s41594-023-01062-z. Epub 2023 Aug 21. Nat Struct Mol Biol. 2023. PMID: 37605043 Free PMC article.
-
Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain.MAbs. 2023 Jan-Dec;15(1):2223350. doi: 10.1080/19420862.2023.2223350. MAbs. 2023. PMID: 37345226 Free PMC article.
-
Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC.Viruses. 2023 May 17;15(5):1185. doi: 10.3390/v15051185. Viruses. 2023. PMID: 37243271 Free PMC article.
References
-
- Eckert DM, Kim PS. Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem. 2001;70:777–810. - PubMed
-
- Colman PM, Lawrence MC. The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol. 2003;4:309–319. - PubMed
-
- Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science. 1998;280:1884–1888. - PubMed
-
- Sattentau QJ. HIV gp120: Double lock strategy foils host defences. Structure. 1998;6:945–949. - PubMed
-
- Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657–700. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials